MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
The medical device space is growing rapidly as new startups and investments from major players enter the market. Some of the most notable investors in medical devices include venture capital firms such as Kleiner Perkins Caufield & Byers, Sequoia Capital, and Accel Partners, as well as large companies such as Johnson & Johnson and Medtronic.
This influx of investment is driving innovation in the medical device space, with new devices and treatments being developed all the time. This growth is also creating opportunities for entrepreneurs, who can now launch their own medical device startups and access funding from major players.
Terumo Neuro Celebrates 15 Years of the WEB Device: A Game-Changing Innovation in Aneurysm Treatment
Carsten Schroeder, President and CEO of Terumo Neuro, commented on this significant milestone: "The WEB device has set a new standard in aneurysm treatment and has been instrumental in our mission to drive game-changing impact in neurovascular care. With 15 years of proven clinical success, WEB continues to advance patient outcomes, reducing the need for multiple devices and lengthy procedures. As we celebrate this achievement, we remain committed to innovating alongside leading physicians worldwide to shape the future of neurovascular care."
Paragonix Technologies Secures Official EU MDR Approval for 5 Organ Preservation Devices
Dr. Lisa Anderson, President of Paragonix Technologies. “This achievement validates our technology’s safety and effectiveness while expanding our ability to serve patients and healthcare providers in critical transplant care across the world. With this approval and the support structure provided by Sweden-based Getinge, we are dedicated to setting new standards in organ preservation, advancing the future of transplantation, and making a global impact."
BiVACOR Total Artificial Heart Successfully Implanted in First Patient in Australia; TAH in Place Over 100 Days
Following weeks of in-hospital monitoring, the patient was the first in the world to be discharged from the hospital with the BiVACOR Total Artificial Heart as he awaited a heart transplant. After having the device for 105 days, a donor heart became available, and the patient received a heart transplant on March 6, 2025.
What Should Pharmacies Know About Child-Resistant and Senior-Friendly Blister Packaging: Key Considerations and Best Practices
Implementing child-resistant and senior-friendly blister packaging is essential for pharmacies to enhance safety and accessibility. Such packaging significantly reduces the risk of accidental poisoning among children by making it difficult for them to open, while remaining easy for seniors to use.
Innovaderm Research Rebrands as Indero | a Dual-Focus CRO
Indero is a dual-focus CRO for dermatology and rheumatology, with over 25 years of experience in clinical research and trial delivery.
Reflow Medical Expands Global Reach with New European Subsidiary in Landsberg am Lech, Germany
Isa Rizk, Co-Founder and CEO of Reflow Medical. “This presence allows us to better address the needs of international markets by providing direct sales solutions and forming key distribution collaborations. Our goal is to deliver breakthrough technologies that support physicians and improve patient outcomes worldwide.”
Vitestro Unveils Aletta ™ | World’s 1st Autonomous Robotic Phlebotomy Device
Aletta is the first and only Autonomous Robotic Phlebotomy Device™ (ARPD™), a unique technology descriptor that establishes a new category of medical robotics dedicated to optimizing blood collection. As the exclusive ARPD™, Aletta sets the global industry standard for automated venous blood draws—enhancing clinical precision, safety, efficiency, and patient experience.
Patients Transmit More Than 15 Million Vitals Using Pylo Remote Monitoring Devices
Patients use Pylo remote monitoring devices to collect and securely transmit health data like blood pressure, weight, blood glucose, oxygen saturation, and pulse rate readings to their care teams. With this data, providers can identify potential health issues early and intervene promptly, preventing potential hospitalizations.
PathMaker Neurosystems Announces Issuance of 3 Patents
"We are pleased to see these latest patent issuances that protect PathMaker's novel technology for the non-invasive treatment of ALS," said Jake Maslow, J.D., Co-Founder and Chief Intellectual Property Officer at PathMaker. "These patents provide additional protection specific to the treatment of ALS that goes beyond the more than 40 issued patents we already have protecting our platform globally."
Medical Device News Magazine
